Pharmaceutical News

RSS

Dr. Stephen Ross’s research into psychedelic medicine expands therapeutic frontiers

In a comprehensive Genomic Press Interview published today, Dr. Stephen Ross, a leading figure in psychedelic medicine at New York University (NYU), reveals how a serendipitous conversation in 2006 launched his journey into investigating psychedelic compounds as potential breakthrough treatments for some of psychiatry's most challenging conditions.

10 Jun 2025

COVID boosters do not harm T-cell function in the vulnerable

Findings indicate that frequent COVID-19 booster shots do not weaken T-cell responses, alleviating concerns for vulnerable groups facing new variants.

9 Jun 2025

Statins linked to lower death rates in critically ill sepsis patients

Sepsis is when the immune system overshoots its inflammatory reaction to an infection, so strongly that the vital organs begin to shut down.

6 Jun 2025

Wayne State researchers investigate effects of fentanyl use during pregnancy

A new National Institutes of Health (NIH) grant will aid Wayne State University researchers in measuring the effects of fentanyl during pregnancy on maternal behaviors and offspring at birth through early development.

5 Jun 2025

Common antibiotic shows promise in reducing preterm births

A study of almost 1000 pregnant women in Zimbabwe found that a daily dose of a commonly used, safe and inexpensive antibiotic may have led to fewer babies being born early.

5 Jun 2025

Statins show no additional benefit for depression treatment

Lipid-lowering medicines, known as statins, are prescribed in cases of high cholesterol levels, to reduce the risk of atherosclerosis, heart attack and stroke.

4 Jun 2025

Mass treatment with the antibiotic azithromycin may lead to increased drug resistance

Efforts to reduce child mortality in Africa via mass treatment with the antibiotic azithromycin (AZM) may lead to increased drug resistance in bacteria that frequently cause pneumonia and meningitis, highlighting the need for careful monitoring, finds a new study led by UCL.

4 Jun 2025

AI-designed drug shows early promise for lung fibrosis patients in clinical trial

Researchers report that rentosertib, an AI-discovered TNIK inhibitor, showed promising safety and potential to improve lung function in patients with idiopathic pulmonary fibrosis in a 12-week phase 2a clinical trial. The highest dose group demonstrated a trend toward increased forced vital capacity, especially among patients not receiving standard antifibrotic therapy, supporting further clinical investigation.

4 Jun 2025

AI and human scientists collaborate to discover new cancer drug combinations

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used to treat conditions such as high cholesterol and alcohol dependence – could also be effective at treating cancer, a promising new approach to drug discovery.

4 Jun 2025

Early camizestrant therapy keeps advanced breast cancer in check

Switching to camizestrant, a next-generation oral SERD, significantly prolongs progression-free survival and maintains quality of life in patients with ESR1-mutated, hormone receptor-positive advanced breast cancer. The proactive, biomarker-guided approach allows earlier intervention and may redefine standard care.

3 Jun 2025

Ochsner Health shares roadmap for pharmacogenomics integration into clinical practice

In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system delves into the multifaceted implementation of pharmacogenomics-a rapidly evolving field that examines how genetics influence individual responses to medication.

3 Jun 2025

New study stands to improve the rigor and reliability of psychedelic clinical trials

As psychedelics gain traction as potential treatments for mental health disorders, an international study led by researchers at McGill University, Imperial College London, and the University of Exeter stands to improve the rigor and reliability of clinical research.

3 Jun 2025

New analytical method enhances safety evaluation of metal-based nanomedicines

Nanomedicines, especially those based on nanoparticles, are revolutionizing healthcare in terms of both diagnostics and therapeutics.

29 May 2025

Oral 8-aminoguanine protects aging eyes and preserves vision in preclinical study

Oral 8-aminoguanine (8-AG) treatment preserved retinal structure and rod function in aged Fischer 344 rats, significantly reducing oxidative stress and inflammation. These findings highlight the promise of 8-AG as a non-invasive intervention to slow age-related retinal degeneration.

27 May 2025

Traditional South Asian medicinal plants show promise in addressing memory disorders

The growing global population of elderly individuals has led to a dramatic rise in chronic diseases, including neurocognitive disorders such as Alzheimer's disease.

27 May 2025

Integrating pharmacogenomics into everyday clinical practice can transform patient care

Pharmacogenomics studies how individuals respond to drugs based on their genetic code. Using that knowledge to guide prescribing in routine care could lead to better outcomes for patients and save money for health systems.

26 May 2025

Researchers prolong ketamine’s antidepressant benefits to two months

Roughly 10 percent of the U.S. population is afflicted with major depressive disorder at any given time, and up to 20 percent will exhibit MDD symptoms over their lifetimes.

22 May 2025

Catalpol shows neuroprotective effects across multiple neurologic conditions

Announcing a new publication for Acta Materia Medica journal. Neurologic disorders are the leading cause of illness and disability as a result of increased life expectancy and global population aging, highlighting the urgent need and great challenge for discovering neuroprotective agents with better efficacy and minimal side-effects.

22 May 2025

Research reveals the impact of cannabis laws on traditional prescriptions

Approval of recreational and medical cannabis laws in most U.S. states has allowed individuals to legally obtain cannabis to treat certain medical ailments that had typically been treated with prescription drugs.

22 May 2025

Long-term antidepressant use linked to higher risk of withdrawal symptoms

People who have been taking antidepressants for more than two years are substantially more likely to experience withdrawal symptoms compared to short-term users when they come off the medication, finds a new study led by UCL researchers.

21 May 2025

Pharmaceutical News

Dr. Stephen Ross’s research into psychedelic medicine expands therapeutic frontiers

COVID boosters do not harm T-cell function in the vulnerable

Statins linked to lower death rates in critically ill sepsis patients

Wayne State researchers investigate effects of fentanyl use during pregnancy

Common antibiotic shows promise in reducing preterm births

Statins show no additional benefit for depression treatment

Mass treatment with the antibiotic azithromycin may lead to increased drug resistance

AI-designed drug shows early promise for lung fibrosis patients in clinical trial

AI and human scientists collaborate to discover new cancer drug combinations

Early camizestrant therapy keeps advanced breast cancer in check

Ochsner Health shares roadmap for pharmacogenomics integration into clinical practice

New study stands to improve the rigor and reliability of psychedelic clinical trials

New analytical method enhances safety evaluation of metal-based nanomedicines

Oral 8-aminoguanine protects aging eyes and preserves vision in preclinical study

Traditional South Asian medicinal plants show promise in addressing memory disorders

Integrating pharmacogenomics into everyday clinical practice can transform patient care

Researchers prolong ketamine’s antidepressant benefits to two months

Catalpol shows neuroprotective effects across multiple neurologic conditions

Research reveals the impact of cannabis laws on traditional prescriptions

Long-term antidepressant use linked to higher risk of withdrawal symptoms

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Latest News